Albumin–globulin ratio (AGR) as independent predictor of poor survival in renal cell carcinoma: A systematic review and meta-analysis

References

• Hsieh JJ, Purdue MP, Signoretti S, et al. Renal cell carcinoma. Nat Rev Dis Primers. 2017 Mar 9;3(1):17009. doi: 10.1038/nrdp.2017.9
   PubMed Web of Science ®Google Scholar
• Ljungberg B, Albiges L, Abu-Ghanem Y, et al. European Association of Urology guidelines on renal cell carcinoma: the 2022 update. Eur Urol. 2022 Oct;82(4):399–410. doi: 10.1016/j.eururo.2022.03.006
   PubMed Web of Science ®Google Scholar
• Bukavina L, Bensalah K, Bray F, et al. Epidemiology of renal cell carcinoma: 2022 update. Eur Urol. 2022 Nov;82(5):529–542. doi: 10.1016/j.eururo.2022.08.019
   PubMed Web of Science ®Google Scholar
• Padala SA, Barsouk A, Thandra KC, et al. Epidemiology of renal cell carcinoma. World J Oncol. 2020 Jun;11(3):79–87. doi: 10.14740/wjon1279
   PubMedGoogle Scholar
• McMillan DC. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care. 2009 May;12(3):223–226. doi: 10.1097/MCO.0b013e32832a7902
   PubMed Web of Science ®Google Scholar
• Hariyanto TI, Kurniawan A. Appetite problem in cancer patients: pathophysiology, diagnosis, and treatment. Cancer Treat Res Commun. 2021;27:100336. doi: 10.1016/j.ctarc.2021.100336
   PubMedGoogle Scholar
• Van Cutsem E, Arends J. The causes and consequences of cancer-associated malnutrition. Eur J Oncol Nurs. 2005;9(Suppl 2):S51–63. doi: 10.1016/j.ejon.2005.09.007
   PubMedGoogle Scholar
• Lv GY, An L, Sun XD, et al. Pretreatment albumin to globulin ratio can serve as a prognostic marker in human cancers: a meta-analysis. Clin Chim Acta. 2018 Jan;476:81–91. doi: 10.1016/j.cca.2017.11.019
   PubMed Web of Science ®Google Scholar
• Li J, Wang Y, Wu Y, et al. Prognostic value of pretreatment albumin to globulin ratio in lung cancer: a meta-analysis. Nutr Cancer. 2021;73(1):75–82. doi: 10.1080/01635581.2020.1737155
   PubMed Web of Science ®Google Scholar
• Wei C, Yu Z, Wang G, et al. Low pretreatment albumin-to-globulin ratio predicts poor prognosis in gastric cancer: insight from a meta-analysis. Front Oncol. 2021 Jan 26;10:623046. doi: 10.3389/fonc.2020.623046
   PubMed Web of Science ®Google Scholar
• Quan L, Jiang X, Jia X, et al. Prognostic value of the albumin-to-globulin ratio in patients with colorectal cancer: a meta-analysis. Nutr Cancer. 2022;74(9):3329–3339. doi: 10.1080/01635581.2022.2076890
   PubMed Web of Science ®Google Scholar
• Wang YT, Kuo LT, Lai CH, et al. Low pretreatment albumin-to-globulin ratios predict poor survival outcomes in patients with head and neck cancer: a systematic review and meta-analysis. J Cancer. 2023 Jan 9;14(2):281–289. doi: 10.7150/jca.80955
   PubMed Web of Science ®Google Scholar
• Chen Z, Shao Y, Yao H, et al. Preoperative albumin to globulin ratio predicts survival in clear cell renal cell carcinoma patients. Oncotarg. 2017 Jul 18;8(29):48291–48302. doi: 10.18632/oncotarget.15162
   PubMedGoogle Scholar
• Koparal MY, Polat F, Çetin S, et al. Prognostic role of preoperative albumin to globulin ratio in predicting survival of clear cell renal cell carcinoma. Int braz j urol. 2018 Sep–Oct;44(5):933–946. doi: 10.1590/S1677-5538.IBJU.2018.0012
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71
   PubMed Web of Science ®Google Scholar
• Margulis AV, Pladevall M, Riera-Guardia N, et al. Quality assessment of observational studies in a drug-safety systematic review, comparison of two tools: the Newcastle–Ottawa scale and the RTI item bank. Clin Epidemiol. 2014 Oct 10;6:359–368. doi: 10.2147/CLEP.S66677
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003 Sep 6;327(7414):557–560. doi: 10.1136/bmj.327.7414.557
   PubMed Web of Science ®Google Scholar
• Thornton A. Publication bias in meta-analysis: its causes and consequences. J Clin Epidemiol. 2000 Feb;53(2):207–216. doi: 10.1016/s0895-4356(99)00161-4
   PubMed Web of Science ®Google Scholar
• Aktepe OH, Güner G, Güven DC, et al. Impact of albumin to globulin ratio on survival outcomes of patients with metastatic renal cell carcinoma. Turk J Urol. 2021 Mar;47(2):113–119. doi: 10.5152/tud.2021.20377
   PubMed Web of Science ®Google Scholar
• Chung JW, Park DJ, Chun SY, et al. The prognostic role of preoperative serum albumin/globulin ratio in patients with non-metastatic renal cell carcinoma undergoing partial or radical nephrectomy. Sci Rep. 2020 Jul 20;10(1):11999. doi: 10.1038/s41598-020-68975-3
   PubMed Web of Science ®Google Scholar
• He X, Guo S, Chen D, et al. Preoperative albumin to globulin ratio (AGR) as prognostic factor in renal cell carcinoma. J Cancer. 2017 Jan 15;8(2):258–265. doi: 10.7150/jca.16525
   PubMed Web of Science ®Google Scholar
• Hu J, Chen J, Li H, et al. A preoperative nomogram predicting the pseudocapsule status in localized renal cell carcinoma. Transl Androl Urol. 2020 Apr;9(2):462–472. doi: 10.21037/tau.2020.01.26
   PubMed Web of Science ®Google Scholar
• Laukhtina E, Pradere B, D’Andrea D, et al. Prognostic effect of preoperative serum albumin to globulin ratio in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma. Transl Androl Urol. 2021 Feb;10(2):609–619. doi: 10.21037/tau-20-1101
   PubMed Web of Science ®Google Scholar
• Mao W, Zhang N, Wang K, et al. Combination of albumin-globulin score and sarcopenia to predict prognosis in patients with renal cell carcinoma undergoing laparoscopic nephrectomy. Front Nutr. 2021 Sep 23;8:731466. doi: 10.3389/fnut.2021.731466
   PubMed Web of Science ®Google Scholar
• Terrin N, Schmid CH, Lau J, et al. Adjusting for publication bias in the presence of heterogeneity. Stat Med. 2003 Jul 15;22(13):2113–2126. doi: 10.1002/sim.1461
   PubMed Web of Science ®Google Scholar
• Nicholson JP, Wolmarans MR, Park GR. The role of albumin in critical illness. Br J Anaesth. 2000 Oct;85(4):599–610. doi: 10.1093/bja/85.4.599
   PubMed Web of Science ®Google Scholar
• Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J. 2010 Dec 22;9(1):69. doi: 10.1186/1475-2891-9-69
   PubMed Web of Science ®Google Scholar
• Soeters PB, Wolfe RR, Shenkin A. Hypoalbuminemia: pathogenesis and clinical significance. JPEN J Parenter Enteral Nutr. 2019 Feb;43(2):181–193. doi: 10.1002/jpen.1451
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation. Nature. 2008 Jul 24;454(7203):436–444. doi: 10.1038/nature07205
   PubMed Web of Science ®Google Scholar
• Elinav E, Nowarski R, Thaiss CA, et al. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer. 2013 Nov;13(11):759–771. doi: 10.1038/nrc3611
   PubMed Web of Science ®Google Scholar
• Cabrerizo S, Cuadras D, Gomez-Busto F, et al. Serum albumin and health in older people: review and meta analysis. Maturitas. 2015 May;81(1):17–27. doi: 10.1016/j.maturitas.2015.02.009
   PubMed Web of Science ®Google Scholar
• Deng Y, Pang Q, Miao RC, et al. Prognostic significance of pretreatment albumin/globulin ratio in patients with hepatocellular carcinoma. Onco Targets Ther. 2016 Aug 24;9:5317–5328. doi: 10.2147/OTT.S109736
   PubMed Web of Science ®Google Scholar
• Suh B, Park S, Shin DW, et al. Low albumin-to-globulin ratio associated with cancer incidence and mortality in generally healthy adults. Ann Oncol. 2014 Nov;25(11):2260–2266. doi: 10.1093/annonc/mdu274
   PubMed Web of Science ®Google Scholar
• Tanaka S, Okamoto Y, Yamazaki M, et al. Significance of hyperglobulinemia in severe chronic liver diseases–with special reference to the correlation between serum globulin/IgG level and ICG clearance. Hepatogastroenterology. 2007 Dec;54(80):2301–2305.
   PubMedGoogle Scholar